QuiVad

Home / France / Innate Pharma

Innate Pharma

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 4.07% on April 4, 2017. The shaded band is the year shown above.

April 15, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

330 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 4, 2016Millennium International Management LP0.70%October 21, 2016
August 3, 2016Millennium International Management LP0.64%October 21, 2016
August 2, 2016Millennium International Management LP0.52%October 21, 2016
July 18, 2016Great Point Partners, LLC0.51%March 13, 2017
February 25, 2016Oxford Asset Management LLP0.48%February 29, 2016
February 11, 2016Oxford Asset Management LLP0.56%February 29, 2016
February 4, 2016Oxford Asset Management LLP0.69%February 29, 2016
January 4, 2016Oxford Asset Management LLP0.79%February 29, 2016
December 14, 2015GSA Capital Partners LLP0.49%December 16, 2015
December 8, 2015GSA Capital Partners LLP0.59%December 16, 2015
December 7, 2015Oxford Asset Management LLP0.89%February 29, 2016
December 4, 2015GSA Capital Partners LLP0.61%December 16, 2015
December 3, 2015GSA Capital Partners LLP0.59%December 16, 2015
December 1, 2015GSA Capital Partners LLP0.63%December 16, 2015
November 27, 2015GSA Capital Partners LLP0.54%December 16, 2015
November 17, 2015Oxford Asset Management LLP0.99%February 29, 2016
October 30, 2015GSA Capital Partners LLP0.48%November 3, 2015
October 14, 2015GSA Capital Partners LLP0.56%November 3, 2015
August 27, 2015GSA Capital Partners LLP0.60%November 3, 2015
August 26, 2015GSA Capital Partners LLP0.59%November 3, 2015
August 25, 2015GSA Capital Partners LLP0.60%November 3, 2015
August 14, 2015GSA Capital Partners LLP0.50%November 3, 2015
July 16, 2015GSA Capital Partners LLP0.43%July 20, 2015
June 29, 2015GSA Capital Partners LLP0.51%July 20, 2015
June 16, 2015Oxford Asset Management LLP1.01%February 29, 2016
June 10, 2015Oxford Asset Management LLP0.90%February 29, 2016
May 28, 2015GSA Capital Partners LLP0.48%June 1, 2015
May 26, 2015GSA Capital Partners LLP0.50%June 1, 2015
May 22, 2015GSA Capital Partners LLP0.49%May 27, 2015
May 21, 2015GSA Capital Partners LLP0.50%May 27, 2015
May 20, 2015GSA Capital Partners LLP0.48%May 22, 2015
May 14, 2015GSA Capital Partners LLP0.59%May 22, 2015
April 24, 2015Marshall Wace LLP0.33%April 28, 2015
April 15, 2015Marshall Wace LLP1.15%April 28, 2015
April 14, 2015Worldquant, LLC0.44%April 16, 2015
April 13, 2015Worldquant, LLC0.54%April 16, 2015
April 9, 2015Worldquant, LLC0.68%April 16, 2015
April 8, 2015Marshall Wace LLP1.09%April 28, 2015
April 8, 2015Worldquant, LLC0.77%April 16, 2015
April 2, 2015Worldquant, LLC0.92%April 16, 2015
April 1, 2015Worldquant, LLC0.81%April 16, 2015
March 31, 2015Worldquant, LLC0.73%April 16, 2015
March 31, 2015GSA Capital Partners LLP0.63%May 22, 2015
March 30, 2015Worldquant, LLC0.64%April 16, 2015
March 27, 2015Worldquant, LLC0.51%April 16, 2015
March 23, 2015Marshall Wace LLP1.10%April 28, 2015
March 9, 2015Marshall Wace LLP1.00%April 28, 2015
March 6, 2015Marshall Wace LLP0.90%April 28, 2015
March 4, 2015Marshall Wace LLP0.81%April 28, 2015
March 2, 2015Marshall Wace LLP0.73%April 28, 2015

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Innate Pharma, source AMF, data as at January 28, 2022, https://www.quivad.com/action/innate-pharma?page=5